Anúncio
Anúncio

ABVC

ABVC logo

ABVC BioPharma, Inc. Common Stock

2.19
USD
Patrocinado
-0.06
-2.58%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

2.17

-0.02
-1.00%

Relatórios de Lucros ABVC

Rácio de surpresa positiva

ABVC separação 3 de 8 últimas estimativas.

38%

Próximo Relatório

Data do Próximo Relatório
13 de abr. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
--

ABVC BioPharma, Inc. Common Stock earnings per share and revenue

On 03 de nov. de 2025, ABVC reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, ABVC BioPharma, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 13 de abr. de 2026.
Based on -- analistas, ABVC BioPharma, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio